IL218458D0
Use of aerosolized levofloxacin for treating cystic fibrosis
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
49 members in 26 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 24009209 | United States of America | P | |
| 24923109 | United States of America | P | |
| 2010047903 | United States of America | W | |
| 61240092 | – | – | – |
| 61249231 | – | – | – |
| PCTUS2010047903 | – | – | – |
| US20090240092P | – | – | – |
| US20090249231P | – | – | – |
| WO2010US47903 | – | – | – |
Members49
| Document | Office | Kind | |
|---|---|---|---|
| CA2773033A1 | Canada | A1 | |
| CA2938650A1 | Canada | A1 | |
| WO2011029059A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2010289326A1 | Australia | A1 | |
| IL218458D0This record | Israel | D0 | |
| EP2473170A1 | European Patent Office (EPO) | A1 | |
| MX2012002731A | Mexico | A | |
| KR20120100904A | Republic of Korea | A | |
| CL2012000586A1 | Chile | A1 | |
| CN102724983A | China | A | |
| US2012276153A1 | United States of America | A1 | |
| JP2013503907A | Japan | A | |
| EP2473170A4 | European Patent Office (EPO) | A4 | |
| ZA201202434B | South Africa | B | |
| RU2012111458A | Russian Federation | A | |
| NZ598484A | New Zealand | A | |
| IN2477DEN2012A | India | A | |
| RU2563809C2 | Russian Federation | C2 | |
| AU2010289326B2 | Australia | B2 | |
| AU2015275224A1 | Australia | A1 | |
| JP2016034949A | Japan | A | |
| CA2773033C | Canada | C | |
| AU2015275224B2 | Australia | B2 | |
| US9700564B2 | United States of America | B2 | |
| JP6180012B2 | Japan | B2 | |
| AU2015275224C1 | Australia | C1 | |
| MX353288B | Mexico | B | |
| CA2938650C | Canada | C | |
| US2018085376A1 | United States of America | A1 | |
| RU2015130524A | Russian Federation | A | |
| US10231975B2 | United States of America | B2 | |
| EP2473170B1 | European Patent Office (EPO) | B1 | |
| DK2473170T3 | Denmark | T3 | |
| PT2473170T | Portugal | T | |
| LT2473170T | Lithuania | T | |
| SI2473170T1 | Slovenia | T1 | |
| SMT201900440T1 | San Marino | T1 | |
| HRP20191408T1 | Croatia | T1 | |
| EP3569235A1 | European Patent Office (EPO) | A1 | |
| HUE045469T2 | Hungary | T2 | |
| US2020000817A1 | United States of America | A1 | |
| ES2739979T3 | Spain | T3 | |
| PL2473170T3 | Poland | T3 | |
| BR112012004692A2 | Brazil | A2 | |
| US10792289B2 | United States of America | B2 | |
| CY1121883T1 | Cyprus | T1 | |
| BR112012004692B1 | Brazil | B1 | |
| BR112012004692B8 | Brazil | B8 | |
| US2021228589A1 | United States of America | A1 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent renewedKB | KB | |
| Patent grantedGrantedFF | FF |
Numbers
- Publication, DOCDB
- 218458
- Publication, EPODOC
- IL218458D
- Application
- 218458
- Application, DOCDB
- 21845812
- Application, EPODOC
- IL20120218458
Titles
- English
- USE OF AEROSOLIZED LEVOFLOXACIN FOR TREATING CYSTIC FIBROSIS
Classification
- CPC, 13
- A61K31/5383
- A61K9/0078
- A61K9/08
- A61K33/06
- A61K33/14
- A61K45/06
- A61P11/00
- A61P11/08
- A61P31/04
- A61P37/00
- A61K9/12
- A61K2121/00
- Y02A50/30
- IPC, 1
- A61K